In 2009 The National Institute of Health discovered that there was a direct correlation between gut bacteria and overall human health. This encouraged many investors to start to look towards investing in companies who are willing to commercialize tools that can help discover this correlation. Startups like: uBiome, Viome, Finch Therapeutics, Kallyope, Second Genome, Human Longevity, Maat Pharma and Seed have raised over half-a-billion dollars in just these few short years. Some of these companies sell to big pharma, while others sell directly to consumers. These consumer first companies offer an at home microbiome kit to customers and then offer feedback on what possible changes these consumers can make in their diet to improve their overall health. Read More>>